AAAAAA
Results: 1-25/36
Authors:
Delmas, V
Schulman, CC
Citation: V. Delmas et Cc. Schulman, Untitled, PROG UROL, 11(3), 2001, pp. 415-415
Authors:
Bollens, R
Vanden Bossche, M
Roumeguere, T
Damoun, A
Ekane, S
Hoffmann, P
Zlotta, AR
Schulman, CC
Citation: R. Bollens et al., Extraperitoneal laparoscopic radical prostatectomy - Results after 50 cases, EUR UROL, 40(1), 2001, pp. 65-69
Authors:
Djavan, B
Mazal, P
Zlotta, A
Wammack, R
Ravery, V
Remzi, M
Susani, M
Borkowski, A
Hruby, S
Boccon-Gibod, L
Schulman, CC
Marberger, M
Citation: B. Djavan et al., Pathological features of prostate cancer detected on initial and repeat prostate biopsy: Results of the prospective European Prostate Cancer Detection Study, PROSTATE, 47(2), 2001, pp. 111-117
Authors:
Ziotta, AR
Schulman, CC
Citation: Ar. Ziotta et Cc. Schulman, Can survival he prolonged for patients with hormone-resistant prostate cancer?, LANCET, 357(9253), 2001, pp. 326-327
Authors:
Schulman, CC
Ekane, S
Zlotta, AR
Citation: Cc. Schulman et al., Nutrition and prostate cancer: Evidence or suspicion?, UROLOGY, 58(3), 2001, pp. 318-334
Authors:
Djavan, B
Ravery, V
Zlotta, A
Dobronski, P
Dobrovits, M
Fakhari, M
Seitz, C
Susani, M
Borkowski, A
Boccon-Gibod, L
Schulman, CC
Marberger, M
Citation: B. Djavan et al., Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and4: When should we stop?, J UROL, 166(5), 2001, pp. 1679-1683
Authors:
Schulman, CC
Lock, TMTW
Buzelin, JM
Boeminghaus, F
Stephenson, TP
Talja, M
Citation: Cc. Schulman et al., Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia, J UROL, 166(4), 2001, pp. 1358-1363
Authors:
Schulman, CC
Altwein, JE
Zlotta, AR
Citation: Cc. Schulman et al., Treatment options after failure of local curative treatments in prostate cancer: a controversial issue, BJU INT, 86(9), 2000, pp. 1014-1022
Authors:
Zlotta, AR
Schulman, CC
Citation: Ar. Zlotta et Cc. Schulman, Neoadjuvant and adjuvant hormone therapy for prostate cancer, WORLD J URO, 18(3), 2000, pp. 179-182
Authors:
Schulman, CC
Debruyne, FMJ
Forster, G
Selvaggi, FP
Zlotta, AR
Witjes, WPJ
Citation: Cc. Schulman et al., 4-year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer, EUR UROL, 38(6), 2000, pp. 706-713
Authors:
Djavan, B
Zlotta, AR
Ekane, S
Remzi, M
Kramer, G
Roumeguere, T
Etemad, M
Wolfram, R
Schulman, CC
Marberger, M
Citation: B. Djavan et al., Is one set of sextant biopsies enough to rule out prostate cancer? Influence of transition and total prostate volumes on prostate cancer yield, EUR UROL, 38(2), 2000, pp. 218-224
Authors:
Zlotta, AR
Van Vooren, JP
Huygen, K
Drowart, A
Decock, M
Pirson, M
Jurion, F
Palfliet, K
Denis, O
Simon, J
Schulman, CC
Citation: Ar. Zlotta et al., What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?, EUR UROL, 37(4), 2000, pp. 470-477
Authors:
Zlotta, AR
Schulman, CC
Citation: Ar. Zlotta et Cc. Schulman, Biological response modifiers for the treatment of superficial bladder tumors, EUR UROL, 37, 2000, pp. 10-15
Authors:
Schulman, CC
Citation: Cc. Schulman, Editorial note, EUR UROL, 37(1), 2000, pp. 1-1
Authors:
Zlotta, AR
Schulman, CC
Citation: Ar. Zlotta et Cc. Schulman, Biological markers in superficial bladder tumors and their prognostic significance, UROL CLIN N, 27(1), 2000, pp. 179
Authors:
Schulman, CC
Zlotta, AR
Denis, L
Schroder, FH
Sakr, WA
Citation: Cc. Schulman et al., Prevention of prostate cancer, SC J UROL N, 34, 2000, pp. 50-61
Authors:
Djavan, B
Zlotta, A
Remzi, M
Ghawidel, K
Basharkhah, A
Schulman, CC
Marberger, M
Citation: B. Djavan et al., Optimal predictors of prostate cancer on repeat prostate biopsy: A prospective study of 1,051 men, J UROL, 163(4), 2000, pp. 1144-1148
Authors:
Wespes, E
Sattar, AA
Noel, JC
Schulman, CC
Citation: E. Wespes et al., Does prostaglandin E1 therapy modify the intracavernous musculature?, J UROL, 163(2), 2000, pp. 464-466
Authors:
Zlotta, AR
Van Vooren, JP
Denis, O
Drowart, A
Daffe, M
Lefevre, P
Schandene, L
De Cock, M
De Bruyn, J
Vandenbussche, P
Jurion, F
Palfliet, K
Simon, J
Schulman, CC
Content, J
Huygen, K
Citation: Ar. Zlotta et al., What are the immunologically active components of Bacille Calmette-Guerin in therapy of superficial bladder cancer?, INT J CANC, 87(6), 2000, pp. 844-852
Authors:
Zlotta, AR
Djavan, B
Damoun, M
Roumeguere, T
Petein, M
Entezari, K
Marberger, M
Schulman, CC
Citation: Ar. Zlotta et al., The importance of measuring the prostatic transition zone: an anatomical and radiological study, BJU INT, 84(6), 1999, pp. 661-666
Authors:
Zlotta, AR
Schulman, CC
Citation: Ar. Zlotta et Cc. Schulman, Interstitial laser coagulation for the treatment of benign prostatic hyperplasia using local anaesthesia only, BJU INT, 83(3), 1999, pp. 341-342
Authors:
Zlotta, AR
Djavan, B
Ekane, S
Marberger, M
Schulman, CC
Citation: Ar. Zlotta et al., Is one set of transrectal sextant biopsies enough to rule out prostate cancer? A prospective evaluation, PROSTATE C, 2, 1999, pp. S36-S36
Authors:
Treml, LA
Schulman, CC
Citation: La. Treml et Cc. Schulman, Home health care aides as extenders of therapy services: A managed care pilot program, TOP GERI RE, 14(4), 1999, pp. 34-52
Authors:
Witjes, WPJ
Konig, M
Boeminghaus, FP
Hall, RR
Schulman, CC
Zurlo, M
Fittipaldo, A
Riggi, M
Debruyne, FMJ
Citation: Wpj. Witjes et al., Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder, EUR UROL, 36(6), 1999, pp. 576-581
Authors:
Schulman, CC
Cortvriend, J
Jonas, U
Lock, TMTW
Vaage, S
Speakman, MJ
Citation: Cc. Schulman et al., Tamsulosin: 3-year long-term efficacy and safety in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction: Analysis of a European, multinational, multicenter, open-label study, EUR UROL, 36(6), 1999, pp. 609-620